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ABSTRACT
A high incidence of respiratory infection, including influenza, has been reported at the Hajj in Mecca,
Saudi Arabia. Reported rates of influenza have been higher among UK than among domestic pilgrims,
but this could be explained by methodological differences among studies. Accordingly, the present
study compared the frequencies of respiratory viruses among UK and Saudi pilgrims using the same
study design. Pilgrims with upper respiratory tract symptoms were recruited from Mecca and the
neighbouring valley Mina during the Hajj 2006. Nasal swabs were used for point-of-care influenza
testing and real-time RT-PCR (rtRT-PCR) tests for influenza virus, rhinovirus, parainfluenza virus,
adenovirus, human metapneumovirus and respiratory syncytial virus. Of 260 pilgrims investigated, 150
were from the UK and 110 were Saudi; of these, 38 (25%) UK pilgrims and 14 (13%) Saudi pilgrims had
respiratory infections detectable by rtRT-PCR (p 0.01). In the UK group, there were 19 (13%) cases of
rhinovirus infection, 15 (10%) cases of influenza virus infection, two (1%) cases of dual infections with
influenza virus and rhinovirus, one (3%) case of parainfluenza virus infection, and one (1%) case of
respiratory syncytial virus infection. Fifty-six (37%) UK pilgrims had been vaccinated against influenza
virus, with the rates of influenza in the vaccinated and unvaccinated group being 7% and 14%,
respectively (p 0.19). In the Saudi group, there were three (3%) cases of rhinovirus infection and 11
(10%) cases of influenza. Only four (4%) Saudi pilgrims had been vaccinated against influenza virus,
and none of these was infected with influenza virus. Overall, a significantly higher proportion of the UK
pilgrims had detectable respiratory infections (25% vs. 13%, p 0.01). Influenza rates were similar in both
groups, but the reported rates of influenza vaccination differed.
Keywords Hajj, influenza, pilgrims, respiratory tract infections, vaccination rates, virus infections
Original Submission: 30 October 2007; Revised Submission: 4 January 2008; Accepted: 9 January 2008
Clin Microbiol Infect 2008; 14: 569–574
INTRODUCTION
The Hajj in Mecca, Saudi Arabia, attracts nearly
1.5 million overseas pilgrims from all parts of the
world. With another 0.5 million pilgrims from the
host country, the Hajj is one of the most crowded
annual mass gatherings on the planet [1,2]. The
focal attraction of the pilgrimage is the symbolic
house of God, the Ka’bah, and its surrounding
mountains, and the Holy Mosque (or Grand
Mosque) compound, which confines the pilgrims
in a semi-closed setting. As part of the rituals,
pilgrims circumambulate the Ka’bah for hours in
successive episodes, and then, in the later part of
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the festival, they move in a body to Mina, a valley
on the outskirts of Mecca, where they stay in tents
for several nights, usually in groups of 50–100
individuals in a large tent [2]. Prolonged close
contact, physical exertion and overcrowding in
a semi-closed setting increase the susceptibility
of pilgrims to airborne infections, including
meningococcal disease and influenza [2–4].
A UK study, based on paired serum samples
collected before and after the Hajj, revealed that
38% of returning UK pilgrims suffered from
influenza during the Hajj 2003, while in the same
year, a Saudi Arabian study used virus culture of
pharyngeal swabs collected at the Hajj to reveal
that 6% of symptomatic pilgrims (half were
domestic pilgrims) had influenza [5,6]. Subsequent
surveillance using PCR to investigate nasal sam-
ples from symptomatic UK pilgrims indicated a
14% influenza rate during the Hajj 2005, at a time
when overall influenza virus activity was low
throughout Europe, including the UK [7].
While these studies have consistently revealed
higher rates of influenza among UK pilgrims than
among Saudi pilgrims, it is unclear whether the
differences could be caused by variations in study
design, timing of sample collection, type of
samples obtained and laboratory procedures
applied. In addition, a range of other viruses,
e.g., rhinovirus, parainfluenza virus, adenovirus
and respiratory syncytial virus (RSV), can cause
infections that frequently mimic influenza. Fur-
thermore, human metapneumovirus (hMPV) has
been reported to be an important cause of respi-
ratory infections in children, as well as adults,
since its discovery in 2001 [8], but its incidence
among the Hajj pilgrims is unknown. In this
context, the present investigation used a consis-
tent study design, including sample collection
and laboratory methods, to compare the rates of
influenza virus, rhinovirus, RSV, hMPV, adeno-
virus and parainfluenza virus infection among
UK and Saudi pilgrims suffering from upper
respiratory tract infection (URTI) during the Hajj
2006.
MATERIALS AND METHODS
Case definitions
A UK pilgrim was defined as a traveller from the UK who
suffered from URTI during the Hajj 2006. A Saudi pilgrim was
defined as a native or expatriate resident pilgrim from Saudi
Arabia who suffered from URTI during the Hajj 2006.
Setting
A clinic was established with the British Hajj Delegation
(BHD) team at a hotel close to the Holy Mosque in Mecca in
January 2006. The BHD team is composed of several UK
general practitioners who provide ‘walk-in’ primary-care
services to UK pilgrims. Leaflets containing the address of
the BHD clinic were distributed to the pilgrims during pre-
travel seminars in the UK. Clinics were also established
subsequently in the British block of tents in Mina. Pilgrims
suffering from symptoms of URTI, e.g., cough, sore throat,
rhinorrhoea and fever, were asked to participate in the
study.
The Saudi cohort was recruited from the National
Guard Health Affairs clinic, which is a temporary military
base hospital that provides free primary-care and emer-
gency-care services in Mina for pilgrims in general, but
particularly Saudi (military as well as civilian) pilgrims.
Saudi pilgrims who attended the National Guard Health
Affairs clinic with symptoms of URTI were recruited to the
study.
Invitation letters in English or Arabic, as appropriate,
were handed to the pilgrims, and queries concerning the
study were answered by multilingual research team mem-
bers. Demographical details and other clinical and risk-factor
information were recorded, including presenting
symptoms, past medical, tobacco smoking, contact and
vaccination histories, and axillary temperatures. Two nasal
swabs were taken from each pilgrim. The first was used for
point-of-care testing for influenza virus (QuickVue influenza
test; Quidel Corp., San Diego, CA, USA), and the second
was immersed in lysis buffer for subsequent transport via a
specialist courier service under optimum conditions to the
UK for real-time RT-PCR (rtRT-PCR) assays. Nasal swabs
were chosen, rather than nasal washings or throat swabs,
because they are quicker and more acceptable to pilgrims,
thereby allowing more sampling in the limited time avail-
able. Individuals who yielded positive results according to
the QuickVue test were offered a course of oseltamivir if
symptomatic for <48 h. The study was approved by the
Multicentre Research Ethics Committee, UK (MREC), ref.
No. MREC ⁄ 02 ⁄ 12.
Molecular diagnosis
rtRT-PCR assays were performed at the London South
Specialist Virology Centre, Health Protection Agency, UK.
RNA was extracted in duplicate from 140 lL of each sample
using a QIAamp viral RNA mini kit (Qiagen, Hilden,
Germany), to yield, in total, 160 lL of purified RNA extract.
The RNA extract was then divided into 20-lL aliquots and
frozen at )80C until analysed by rtRT-PCR. One-step rtRT-
PCR analysis was performed using the iScript One-Step
RT-PCR kit for probes on a Bio-Rad iCycler iQ system real-
time thermal cycler (Bio-Rad, Hemel Hempstead, UK).
Extracts were tested for rhinovirus and RSV A and B
(multiplex 1), parainfluenza virus 1, 2 and 3 (multiplex 2),
and hMPV and influenza virus A and B (multiplex 3). The
gene targets were nucleocapsid protein (RSV A and B), 5¢-
UTR (rhinovirus), the HN gene (parainfluenza virus 1, 2 and
3) and the NS gene (influenza virus A and B). Details of
primers, probes and RT-PCR conditions have been described
previously [9,10].
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Statistical analysis
Data were analysed using SPSS v.14 software (SPSS Inc.,
Chicago, IL, USA). Chi-square tests were used to compare
proportions.
RESULTS
In total, 260 pilgrims were recruited to the study,
of whom 150 (58%) were from the UK, and 110
(42%) were Saudi Arabian residents. Their demo-
graphical and other characteristics are summar-
ised in Table 1.
The 150 UK pilgrims were recruited between
2 and 62 (median 16) days after travelling from
the UK. Pilgrims came from throughout the UK,
but large proportions were from London (18%),
Birmingham (8%), Dewsbury (8%) and Batley
(6%). Table 2 summarises the ethnicity and age
distribution of the pilgrims. Fifty-six (37%)
pilgrims had received influenza vaccine
1–3 months before the Hajj, 91 (61%) had defi-
nitely not been vaccinated, and three (2%) were
not sure of their vaccination status.
Of 110 Saudi pilgrims, 36 (32.7%) came from
Mecca and its neighbouring port city Jeddah, and
22 (20%) came from the Saudi capital Riyadh.
Their ethnicity and age distribution are summar-
ised in Table 2. Four (4%) pilgrims had received
influenza vaccine, 103 (94%) had definitely not
been vaccinated, and three (3%) were not sure of
their vaccination status.
Epidemiology
The most common presenting symptoms of the
UK pilgrims were sore throat (72%), cough (68%),
rhinorrhoea (52%) and fever (41%), with positive
predictive values for influenza (not adjusted for
dual ⁄non-influenza infections) of 65%, 76%, 53%
and 53%, respectively. Forty-three (29%) patients
had additional symptoms, e.g., diarrhoea, rash,
abdominal pain, myalgia and headache.
Two (1%) UK pilgrims were positive for
influenza virus according to the QuickVue test,
with both being confirmed by rtRT-PCR. Thirty-
eight (25%) UK pilgrims were positive for at least
one virus according to rtRT-PCR, i.e., 19 (13%)
rhinovirus, 15 (10%) influenza virus, one (1%)
RSV A, one (1%) parainfluenza virus type 3, and
two (1%) dual infections with influenza virus and
rhinovirus. Of the total of 17 (11%) cases of
influenza virus infection, 13 were caused by
influenza A and four by influenza B.
All except one patient (who was diagnosed
with influenza and rhinovirus and presented
within 2 days of arrival) presented ‡7 days after
reaching Mecca. The proportion of rhinovirus in
pilgrims recruited from Mecca (BHD) was higher
than that recruited from Mina (24% vs. 10%,
p 0.03). The proportion of influenza virus was
also higher among recruits from Mecca (17% vs.
9%), but this difference did not reach significance
(p 0.2). Twenty-nine (19%) pilgrims reported
contact with individuals with influenza-like ill-
ness, of whom three had influenza and two had
rhinovirus infection. Sixty-three (42%) pilgrims
denied any such contact, six of whom had
influenza virus, five rhinovirus, one parainflu-
enza virus and one RSV A infection. Fifty-eight
(39%) pilgrims were unsure whether they had
had any such previous contact, six of whom had
influenza virus infection, 12 rhinovirus infection
Table 1. Demographical characteristics and real-time
RT-PCR virus detection results for pilgrims to the Hajj 2006
UK, n (%) Saudi, n (%) p value
Sample size 150 110
Median age, years 41 (range 14–81) 30 (range 16–85)
Male:female 138:12 109:1 0.01
Individuals with chronic diseases 30 (20) 12 (11) 0.05
At-risk individuals 38 (25) 15 (14) 0.02
Vaccinated against influenza 56 (37) 4 (4) <0.001
Smokers of tobacco 16 (11) 30 (27) 0.001
Influenza virus-positive 15 (10) 11 (10) 1.00
Rhinovirus-positive 19 (13) 3 (3) 0.004
RSV-positive 1 (1) 0 (0) 0.39
Parainfluenza virus-positive 1 (1) 0 (0) 0.39
Dual infections (rhinovirus
plus influenza virus)
2 (1) 0 (0) 0.22
RSV, respiratory syncytial virus.
Table 2. Ethnicity and age distribution of pilgrims with
influenza virus and rhinovirus infections
Ethnicity
UK pilgrims Saudi pilgrims
Total
Influenza,
n (%)
Rhinovirus,
n (%) Total
Influenza,
n (%)
Rhinovirus,
n (%)
Pakistani 55 11 (20) 11 (20) 4 1 (25) 0 (0)
Bangladeshi 34 3 (9) 6 (18) 3 1 (33) 0 (0)
Indian 32 3 (9) 2 (6) 1 0 (0) 0 (0)
Saudi 1 0 (0) 0 (0) 68 5 (7) 2 (3)
Sudanese 0 0 (0) 0 (0) 13 2 (15) 0 (0)
Egyptian 0 0 (0) 0 (0) 10 2 (20) 0 (0)
Moroccan 0 0 (0) 0 (0) 7 0 (0) 0 (0)
Others 13 0 (0) 0 (0) 3 0 (0) 1 (33)
Unknown 15 0 (0) 2 (13) 1 0 (0) 0 (0)
Age group, years
<16 1 0 (0) 0 (0) 1 0 (0) 0 (0)
16–25 13 1 (8) 1 (8) 34 3 (9) 2 (6)
26–35 35 4 (11) 3 (9) 31 4 (13) 0 (0)
36–45 34 6 (18) 7 (21) 26 3 (12) 0 (0)
46–55 36 3 (8) 7 (19) 9 1 (11) 0 (0)
56–65 13 2 (15) 2 (15) 3 0 (0) 0 (0)
>65 11 0 (0) 0 (0) 4 0 (0) 0 (0)
Unknown 7 1 (14) 1 (14) 3 0 (0) 1 (33)
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and two dual infections (influenza virus and
rhinovirus).
Common presenting symptoms of Saudi
pilgrims were sore throat (86%), rhinorrhoea
(72%), cough (66%), myalgia (46%) and fever
(43%), with positive predictive values for influ-
enza (not adjusted for dual ⁄non-influenza infec-
tions) of 81%, 64%, 72%, 72% and 91%,
respectively. Nine (8%) pilgrims complained of
diarrhoea, of whom one had influenza virus A
infection.
Seven (6%) Saudi pilgrims were positive for
influenza virus according to the QuickVue test, of
whom three were confirmed by rtRT-PCR. Four-
teen (13%) patients were positive for at least one
virus according to rtRT-PCR, i.e., 11 (10%) influ-
enza virus and three (3%) rhinovirus; no dual
infections were detected. Of 11 influenza viruses
identified, nine (81%) were influenza A and two
(19%) were influenza B.
Eight (7%) Saudi pilgrims reported contact with
an individual suffering from influenza-like illness,
one of whom had influenza. Ninety-six (87%)
pilgrims denied any such contact, ten of whom
had influenza and three had rhinovirus infections.
Risk-group analyses
Thirty-eight (25%) UK pilgrims were considered
to be ‘at risk’ for influenza, 12 because they were
aged ‡65 years, regardless of underlying medical
condition, and the others because of pre-existing
medical conditions, e.g., diabetes (62%) or lung
(23%), heart (12%) and kidney (4%) disease. The
rates of influenza vaccination among ‘at risk’ and
‘not at risk’ pilgrims were 63% (24 ⁄ 38) and 29%
(32 ⁄ 112), respectively (p <0.001), and the corre-
sponding rates of influenza infection were 8%
(3 ⁄ 38) and 13% (14 ⁄ 112), respectively (p 0.44).
Seven pilgrims were known to suffer from
bronchial asthma, but none had influenza or
rhinovirus infections. Overall, the rates of influ-
enza among vaccinated and unvaccinated UK
pilgrims were 7% (4 ⁄ 56) and 14% (13 ⁄ 91),
respectively (p 0.19). Four (24%) UK pilgrims
with confirmed influenza stated that they had
received the vaccine 1–2 months before journey-
ing to the Hajj. Sixteen (11%) UK pilgrims were
tobacco smokers and 103 (69%) were non-smok-
ers; the proportion of influenza virus and rhino-
virus infections among smokers and non-smokers
was similar.
Fifteen (14%) Saudi pilgrims were considered
to be ‘at risk’ for influenza, three because they
were aged ‡65 years, and the others because of
chronic diseases, e.g., diabetes (33.3%) and heart
(33.3%) and lung (33.3%) disease. None of the ‘at
risk’ Saudi pilgrims was vaccinated. The rates of
influenza among ‘at risk’ and ‘not at risk’ Saudi
pilgrims were 13% (2 ⁄ 15) and 9% (9 ⁄ 95), respec-
tively (p 0.64). The rates of influenza among
unvaccinated and vaccinated Saudi pilgrims were
10% (10 ⁄ 103) and 0% (0 ⁄ 4), respectively (p 0.51).
Thirty (27%) Saudi pilgrims were tobacco smok-
ers, and 79 (72%) were non-smokers; the rate of
influenza virus infection among smokers and
non-smokers was similar.
DISCUSSION
UK pilgrims (except one) with PCR-confirmed
infections presented >1 week after reaching the
Hajj, thereby indicating that the infections were
acquired at the Hajj, since the incubation period
for infections caused by influenza virus, rhinovi-
rus, RSV and parainfluenza virus is <7 days. To
have been in compliance with Hajj rites, Saudi
pilgrims must have joined the congregation at
least 2–3 days before they were recruited into the
study. Considering the short incubation period
for influenza, it is reasonable to suppose that the
Saudi pilgrims also acquired the infection at the
Hajj.
In this study of a predominantly male popula-
tion, a significantly higher proportion of infec-
tions was detected among UK pilgrims than
among their Saudi counterparts (25% vs. 13%,
p 0.01). In the UK cohort, rhinovirus was the most
common virus detected (14%), followed by influ-
enza virus, while influenza virus was the com-
monest infectious agent among the Saudi cohort,
followed by a small proportion of rhinovirus
(3%). However, the attack rate of influenza virus
was similar (c. 10%) in both groups, with influ-
enza A predominating. Thus, it appears that
influenza virus was circulating widely at the Hajj,
while rhinovirus was circulating selectively
among the UK pilgrims, particularly those re-
cruited in Mecca City.
The attack rate of influenza virus among UK
pilgrims in the present study was lower (but not
significantly so) than in 2005 (11% vs. 14% [7]),
possibly because of annual variation, although
this may relate to a higher overall vaccine cover-
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age, i.e., 28% in 2005 compared with 37% in 2006
(p 0.06). Immunisation uptake was low in both
years [11]. The rate of influenza among vaccinated
pilgrims was lower than that among unvacci-
nated pilgrims (7% vs. 14%), but this difference
was not statistically significant, which is consis-
tent with findings in previous studies [5,7]. There
are two possible reasons for the failure of influ-
enza vaccine to make a significant difference: (i) a
major proportion of vaccinated pilgrims were ‘at
risk’ individuals who are naturally more suscep-
tible to influenza virus (and in whom vaccine is
less immunogenic) than the unvaccinated group,
most of whom were otherwise healthy and hence
less vulnerable to infection; and (ii) there was a
possible mismatch between the vaccine strains
and circulating strains. Thus, during the Hajj 2004
(in March), the commonest circulating strain of
influenza virus was influenza B Sichuan [12], but
the corresponding vaccine strain was influenza B
Hong Kong for both hemispheres [13,14]. Other
examples of vaccine failure and mismatch among
non-Hajj travellers have been reported [15,16]. It
is open to debate whether the same influenza
vaccine is fully protective in both hemispheres of
the world, particularly in travellers with poor
immunity. Therefore, antiviral drugs should be
considered as an adjunct to vaccination for post-
exposure prophylaxis at the Hajj [17].
More worryingly, despite official Saudi policy,
the reported uptake of influenza vaccine among ‘at
risk’ Saudi pilgrims was nil. Only four (4%) Saudi
‘not at risk’ pilgrims had received the vaccine,
with no improvement in uptake since 2003, when
Balkhy et al. [6] reported 4.4% coverage among
500 international pilgrims, of whom a major
fraction were Saudi. A recent survey also revealed
a very low uptake (5.9%) of influenza vaccine
among Saudi healthcare workers employed at the
Hajj [18]. It seems that a vigorous campaign is
required to improve influenza vaccine coverage
among domestic pilgrims and healthcare workers
at the Hajj.
This is the first study to diagnose rhinovirus
infection from respiratory specimens taken at the
Hajj, although El-Sheikh et al. [19] used serolog-
ical methods to diagnose five (7%) cases of
infection with picorna virus (without species
categorisation) among 76 serum samples taken
at the Hajj in 1991 and 1992, which presumably
were rhinoviruses. However, these viruses were
not detected in virus culture of the throat sam-
ples. Seasonal variations are the likely explana-
tions for the varying results in these two studies.
Scorching summer temperatures during the Hajj
in 1991 and 1992 might have resulted in poor
detection of the virus in the study by El-Sheikh
et al. [19], while the lower temperatures during
the Hajj 2006 might have resulted in greater virus
yields [20]. The frequency of rhinovirus was
significantly higher in the Mecca City area than
in Mina, indicating that rhinovirus was predom-
inantly circulating selectively in the Grand Mos-
que area among certain groups of worshippers
(e.g., UK pilgrims), who later introduced it to
other individuals in their respective blocks of
tents in Mina. Unlike influenza virus, rhinovirus
spreads mainly via close personal contact [21].
The spread of rhinovirus specifically among the
UK pilgrims may have been accelerated by the
crowded conditions at the Grand Mosque during
circumambulation and other prayers, and in local
hotels at least 2 weeks before the domestic pil-
grims attended the Hajj. Choudhry et al. [22]
demonstrated that attendance at a large Mosque
(i.e., Namera mosque in Arafat) increases the risk
of acquiring URTI among Hajj pilgrims. During
the Hajj, the Grand Mosque is more crowded than
any other mosque in the world, facilitating the
spread of respiratory viruses in Mecca City.
Maintenance of good hand hygiene is crucial in
reducing rhinovirus infections, but pilgrims may
not accept alcoholic hand rubs and scented
soaps ⁄detergents, since alcohol is generally for-
bidden in Islam and scented substances are
avoided during the Hajj [23]. Viricidal hand
treatments containing non-alcoholic organic
acids, which have shown excellent results
in preventing rhinovirus transmission among
volunteers, may be acceptable once they become
widely available [24].
Detection rates for RSV (1%) and parainfluenza
virus (1%) were low compared to previous
studies [6,7,19], and adenovirus and hMPV were
not detected. Other important viruses that could
cause influenza-like illness during the Hajj are
coronavirus, enterovirus and human bocavirus
(a newly identified parvovirus) [25,26]. To date,
the highest incidence of the latter virus (18.3%)
has been reported in Jordan [27], a neighbour of
Saudi Arabia, from which thousands of pilgrims
attend the Hajj. Continuing surveillance of respi-
ratory infections at the Hajj should include these
novel viruses and H5N1 influenza virus, to
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protect not only the pilgrims, but also the global
community. Practical issues dictated the descrip-
tive nature of the present study, and some patient
characteristics differed significantly between the
two groups, despite the use of an identical cross-
sectional study design (Table 1). Future studies
will consider the advantages of matching cases as
much as possible before comparing infection
rates.
In summary, both UK and Saudi pilgrims at the
Hajj are at considerable risk of influenza virus
infection. In addition, UK pilgrims develop other
viral infections. Preventive strategies, e.g., vacci-
nation and respiratory hygiene, need to be
enhanced, and antiviral influenza prophylaxis
should be considered. Ongoing surveillance of
influenza and newer respiratory viruses is needed
to better understand the epidemiology of respi-
ratory infections at the Hajj.
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